Quanterix (QTRX) Capital Expenditures (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.35% |
| Dec 31, 2025 | 232.10% |
| Sep 30, 2025 | -332.18% |
| Jun 30, 2025 | -38.14% |
| Mar 31, 2025 | 180.36% |
| Dec 31, 2024 | 133.86% |
| Sep 30, 2024 | -182.74% |
| Jun 30, 2024 | 216.01% |
| Mar 31, 2024 | -86.83% |
| Dec 31, 2023 | 505.60% |
| Sep 30, 2023 | -218.38% |
| Jun 30, 2023 | 444.22% |
| Mar 31, 2023 | 101.49% |
| Dec 31, 2022 | -368.34% |
| Sep 30, 2022 | -26.56% |
| Jun 30, 2022 | 275.06% |
| Mar 31, 2022 | 112.21% |
| Dec 31, 2021 | -385.93% |
| Sep 30, 2021 | -47.33% |
| Jun 30, 2021 | 9,089.87% |
| Mar 31, 2021 | -97.79% |
| Dec 31, 2020 | 456.13% |
| Sep 30, 2020 | -179.67% |
| Jun 30, 2020 | 1,134.31% |
| Mar 31, 2020 | -14.29% |
| Dec 31, 2019 | 101.22% |
| Sep 30, 2019 | -350.06% |
| Jun 30, 2019 | -33.87% |
| Mar 31, 2019 | 548.60% |
| Dec 31, 2018 | -196.42% |
| Sep 30, 2018 | 426.49% |
| Jun 30, 2018 | -193.53% |
| Mar 31, 2018 | 32.15% |
| Dec 31, 2017 | 160.77% |
| Sep 30, 2017 | -77.74% |
| Jun 30, 2017 | 639.24% |